The global gastrointestinal endoscopic devices market size was estimated at USD 11.27 billion in 2024 and is projected to grow at a CAGR of 5.1% from 2025 to 2030. According to the American Cancer Society, approximately 26,380 new cases of stomach cancer were reported in the U.S. in 2022, highlighting the ongoing need for enhanced diagnostic tools such as endoscopy. Moreover, a multinational study by the University of Gothenburg found that over 40% of individuals globally suffer from functional gastrointestinal (GI) disorders, further driving demand for endoscopic procedures.

Technological advancements in endoscopic technology are also playing a significant role in driving market growth. Innovations such as advanced imaging systems, robotic-assisted devices, and enhanced visualization tools facilitate more accurate diagnoses and effective treatments. These advancements make procedures safer and more efficient, driving their adoption in clinical settings. Furthermore, the integration of artificial intelligence and robotic systems into endoscopy is enhancing procedural accuracy and efficiency, providing opportunities for improved patient outcomes.

The preference for minimally invasive surgeries is another key driver of the market. Studies have shown that laparoscopic techniques are used in nearly 80% of colorectal surgeries in North America, reflecting a broader shift toward less invasive options that reduce recovery times and complications. The increasing adoption of minimally invasive techniques is expected to enhance patient outcomes and satisfaction.

Furthermore, public health initiatives in countries such as Brazil have led to a rise in colonoscopy screenings, with reports showing an increase of approximately 25% in screening rates over the past five years. The U.S. Preventive Services Task Force recommends regular screening for colorectal cancer starting at age 45, contributing to a projected increase in screening participation rates among adults by 15% by 2025 as awareness grows. These initiatives are expected to drive demand for endoscopic procedures and enhance patient outcomes.

Curious about the Gastrointestinal Endoscopic Devices Market? Download your FREE sample copy now and get a sneak peek into the latest insights and trends.

Gastrointestinal Endoscopic Devices Market Report Segmentation

 Grand View Research has segmented the global gastrointestinal endoscopic devices market report based on type, end use, and region:

• Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Rigid Gastrointestinal Endoscopes
    • Gastroscope (Upper GI Endoscope)
    • Enteroscope
    • Sigmoidoscope
    • Duodenoscope
  • Flexible Gastrointestinal Endoscopes
    • Gastroscope (Upper GI Endoscope)
    • Enteroscope
    • Sigmoidoscope
    • Duodenoscope
    • Colonoscope
  • Disposable Gastrointestinal Endoscopes
    • Gastroscope (Upper GI Endoscope)
    • Enteroscope
    • Sigmoidoscope
    • Duodenoscope
    • Colonoscope
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
    • Hospitals
    • Outpatient Facilities
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Denmark
      • Sweden
      • Norway
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia
      • South Korea
      • Thailand
    • Latin America
      • Brazil
      • Argentina
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Kuwait

Key Gastrointestinal Endoscopic Devices Insights

Some key companies operating in the market include Olympus Corporation; Boston Scientific Corporation; Medtronic; Johnson & Johnson Services, Inc. (Ethicon Inc.); KARL STORZ SE & Co. KG; among others. Major players are leveraging product innovation and strategic partnerships to strengthen their market presence, focusing on advanced technologies such as robotic-assisted endoscopes and disposable devices.

• Boston Scientific Corporation is a premier provider of gastrointestinal endoscopic devices, featuring an extensive portfolio that includes stents, balloons, clips, and retrieval instruments. Their advanced technologies, such as the AXIOS Stent, significantly enhance minimally invasive procedures and improve patient outcomes.
• Fujifilm Holdings Corporation is a key competitor in the gastrointestinal endoscopic devices sector, specializing in endoscopic systems and imaging technologies. Their extensive product range focuses on advanced visualization and diagnostics, enhancing procedural efficiency and patient care in endoscopy.

Key Gastrointestinal Endoscopic Devices Companies:

The following are the leading companies in the gastrointestinal endoscopic devices market. These companies collectively hold the largest market share and dictate industry trends.

• Olympus Corporation
• Boston Scientific Corporation
• Medtronic
• Johnson & Johnson Services, Inc. (Ethicon Inc.)
• KARL STORZ SE & Co. KG
• Fujifilm Holdings Corporation
• Stryker
• HOYA Corporation (PENTAX Medical)
• Smith+Nephew
• Cook
• CONMED Corporation
• Ambu A/S
• Richard Wolf GmbH
• STERIS plc

Recent Developments

• In December 2024, PENTAX Medical received FDA 510(k) clearance for its new i20c Video Endoscope Series models, enhancing detection, diagnosis, and therapy through advanced imaging and improved ergonomics for healthcare professionals.
• In October 2024, Cook Medical launched the U.S. distribution of PillSense, an FDA-approved GI bleed detection system, allowing rapid identification of upper gastrointestinal bleeding in under 10 minutes for efficient patient triage.
• In September 2024, Olympus Latin America launched the EVIS X1 endoscopy system in Brazil, hosting events featuring expert lectures on colorectal cancer and demonstrations of advanced visualization technologies.
• In August 2024, Ambu announced CE mark approval for its new generation duodenoscopy solution, Ambu aScope Duodeno 2 and aBox 2, enhancing workflow efficiency and infection control in ERCP procedures.
• In April 2024, Medtronic unveiled its AI innovations for endoscopic care at the Genius Summit, introducing ColonPRO software and announcing a strategic collaboration with Modernizing Medicine to enhance patient workflow efficiency.
• In January 2024, KARL STORZ acquired British AI firm Innersight Labs to enhance its healthcare portfolio with innovative 3D modeling software, supporting more efficient and effective surgical procedures for medical professionals.

Order a free sample PDF of the Gastrointestinal Endoscopic Devices Market Intelligence Study, published by Grand View Research.